Bladder cancer: the value of routine bone scintigraphy

Area of Science:

• Oncology
• Nuclear Medicine
• Urology

Background:

• Invasive bladder cancer staging is crucial for treatment planning.
• Bone metastases are a significant concern in advanced bladder cancer.
• The role of routine bone scintigraphy in bladder cancer staging requires evaluation.

Purpose of the Study:

• To assess the utility of routine bone scintigraphy in staging patients with invasive bladder cancer.
• To determine the sensitivity and predictive value of skeletal scintigraphy for detecting bone metastases at diagnosis.

Main Methods:

• Retrospective analysis of 221 patients with invasive bladder cancer.
• Inclusion of routine bone scintigraphy as part of tumor staging.
• Calculation of incidence of detectable metastases, sensitivity, and predictive values.

Main Results:

• 12% of patients presented with detectable bone metastases.
• Skeletal scintigraphy demonstrated a sensitivity of only 38% for detecting metastases.
• The predictive value of a negative bone scan was 92%.

Conclusions:

• Routine bone scintigraphy is not indicated as a standard staging procedure for bladder cancer.
• The low sensitivity of skeletal scintigraphy limits its effectiveness in identifying early bone metastases.
• Alternative or additional staging methods may be more appropriate for bladder cancer patients.